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INTRODUCTION
The -focus o-f the work completed under this contract has
been in the area of phase partitioning, which has become an
important tool -For the separation and purification of biological
materials. Instruments available for this technique were
researched and a countercurrent distribution apparatus, the
Biosheff MK2N, was purchased from the Biochemistry Department
of the University of Sheffield. Sheffield, England, and
delivered to NASA. Various proteins, polysaccharides and cells
were studied as models to determine operating procedures and
conditions for this piece of equipment. Results were compared
with those obtained from other similar equipment, including a
nonsynchronous coil planet centrifuge device built by Y. Ito and
lent to NASA by NIH. Additionally, work was done with affinity
ligands attached to PEB, which can further enhance the separation
capabilities of phase partitioning.
The most important aspects of the work performed during
this contract period have been compiled into two manuscripts
(attached as an appendix to this report), one of which has been
published in the Journal of Liquid Chromatography. The second
manuscript has been accepted for publication in the Journal of
Chromatography. Also included is an abstract of a presentation
delivered in Lund, Sweden at the 4th International Conference on
Partitioning in Aqueous Two-Phase Systems in August. 1985.
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BACKGROUND
When mixed in low concentrations, aqueous solutions of the
polymers poly(ethylene glycol) (PEG) and dextran form a
two-phase system with a PEG-rich upper phase floating on a
denser, dextran-rich lower phase. With the addition of salts
and buffers, these solutions can be made isotonic and have
become important in both analytical and preparative separations
of many types of biological substances (see Appendix for
references). These separations occur because of differential
partitioning between the upper and lower phases, or between one
of the phases and the interface, for particulate substances.
Factors which influence the partition of particles or
macromolecules include size, surface charge, surface
hydrophobicity and system characteristics such as interfacial
tension and salt composition. Separations can sometimes be
enhanced through the use o-f affinity ligands, specific for the
material of interest, which have been chemically attached to one
of the polymers (typically PEG) and, in effect, pull the target
substance into the phase rich in that polymer.
When differences in the partition coefficient K (the ratio
of the number of cells in the top phase to the remainder of
cells) are great enough, samples can be separated in a single
tube. However, in most cases, differences are not that large and
subsequent extractions are necessary, using automated devices
such as a countercurrent distribution (CCD) apparatus.
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MATERIALS AND METHODS
Materials and methods used for the experiments described
below can be -found in detail in the Appendix.
RESULTS
Results obtained using the Biosheff WK2N thin-layer CCD
apparatus were compared with a nonsynchronous coil planet
centrifuge (NSCPC) designed by Y. Ito -for countercurrent
chromatography, and two other thin-layer CCD devices; one
automated, designed by P.A. Albertsson, Lund, Sweden, and the
other a manual model designed by J.A. Van Alstine, Huntsville,
Alabama.
All the thin-layer CCD devices gave similar results, with
partitioning pro-files o-f trypan blue dye, proteins and various
species of red blood cells (both fixed and fresh) being in close
agreement with calculated theoretical curves. Theoretical
predictions for separation with the NSCPC apparatus are
considerably more complicated. However, comparison of
partitioning profiles of cells, in systems yielding similar
partition coefficients, showed a less than efficient mixing of
phases in the NSCPC device, with one run being comparable to
twenty to thirty transfers in the CCD devices. Comments
regarding advantages and disadvantages of the two kinds of
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systems, as well as appropriate references can be found in the
Appendix.
Studies performed with affinity ligands to determine their
ability to refine separation capabilities of phase partitioning
have included using specific ligands (antibodies), to which PEG is
covalently attached, to cause substantial changes in the
partition coefficient of a particular cell type. As models,
rabbit antibody directed against human red blood cells (HRBC)
and sheep antibody, also directed against HRBC, were used. PEG
molecules were covalently coupled to a portion of the lysine
residues of the antibodies, in the laboratory of Dr. J. Milton
Harris, University of Alabama in Huntsville, Huntsville,
Alabama. The PEG—modified antibodies were incubated with both HRBC
and sheep red blood cells (SRBC) causing a dramatic shift in the
partition coefficient of the HRBC but no difference in that of the
SRBC.
As well as increasing its affinity for the PEG-rich upper
phase, the modification of the antibody with PEG decreases its
tendency to agglutinate HRBC. These effects can be varied by
changing the molecular weight of the PEG used for modification
and the number of antibody lysine groups modified. The increase
in partition coefficient of HRBC which have been incubated with
PEG-modified antibody is directly related to the concentration of
antibody used, as seen in the figure that follows.
~OF POOR QUALITY
8 16 32 64 128
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Incuba"fci°n Concentration of PEG-modified Antibody (ug/ml)
ExperimPnts were performed to demonstrate that one cell
population ca31"1 be selectively separated from a mixture of cells
by the use o- PEG-modified antibody ligands. Using a two-phase
system in wh:-ch both SRBC and HRBC ordinarily exhibit
overlapping C-CD profiles, a mixture of the two cell types were
completely separated in 3O transfers following a single
incubation with the PEG-modified antibody (see Appendix for
complete details and references). Having demonstrated that, in
this erythrotyte model system, F'EG-modified antibodies can be
used as effective affinity ligands in phase partitioning, it is
important to continue these studies with other cell types of
biomedical si <3ni * icance such as T-lymphocyte subsets or
megakaryocytP precursors.
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RELATED WORK IN PROGRESS
Another possible use for PEG-modifled antibody -for cell
separation techniques is in the area of electrophoresis. In
preliminary experiments, varying concentrations of PEG-modified
rabbit antibody (directed against HRBC) were incubated with HRBC
and their electrophoretic mobilities were measured. As expected
from previous work with PEG coatings (1.2.3), the mobilities of
HRBC decreased with corresponding increases in incubation
concentrations of PEG—modified antibody. Results seem promising
and continuing studies may lead to electrophoretic separation of
cell populations after the alteration of their surface
properties with PEG-modifled specific antibody.
Other experiments performed under this contract with
affinity phase partitioning have used lectins as ligands.
Lectins are proteins, usually of plant origin, which bind
specifically to certain sugars (much as antibodies bind to their
specific antigen) (4). Many cells have sugar moieties on their
surface to which lectins can bind and various separation
techniques using lectins, such as differential agglutination,
affinity chromatography, and fluorescence activated cell sorting,
have been described (5,6,7). Lectins have some advantages over
antibodies -for use in affinity partitioning. They are less
expensive and are readily available in large quantities.
Additionally, unlike antibodies, lectins can be easily removed
from the cell surface by adding a large excess of the specific
sugar to which they bind.
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Preliminary experiments have been performed utilizing a
PEG-modi-f i ed lectin, wheat germ agglutinin (WGA) , and human
peripheral blood lymphocytes. Bourguignon et al (8) reported
unequal binding of T and B lymphocytes to WGA which allowed for
their separation using a differential agglutination technique.
In single tube partition experiments utilizing PEG-modifled WGA,
the partition coefficients of all lymphocytes were increased
over the controls without the lectin. In these experiments,
there appeared to be no preferential increase in partitioning of
B lymphocytes over that of T lymphocytes, as was hoped.
However, the increase noted for all lymphocytes was a positive
result and continued experiments are planned with further
preparations which vary in the percentage of WGA lysines that
are modified with PEG, and using several incubation
concentrations.
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- anSTRACT
Poly (e thylene glycol) ( P E G ) was c o v a l e n t t y coup led to IgG
^
. i n t i b o d y preparations d i rec ted a g a i n s t h u m a n r ed blood ce l l s .
This m o d i f i c a t i o n r e d u c e s t h e t e n d e n c y o f t h e a n t i b o d y t o
a g g l u t i n a t e cells and increases i t s a f f i n i t y fo r the P E G - r i c h
phase in dext ran-PEG aqueous two phase sys t ems . These e f f e c t s
a r e r e l a t e d t o t h e m o l e c u l a r w e i g h t o f t h e P E G used f o r
m o d i f i c a t i o n and to the number of PEG molecules a t t a c h e d to the
%a nt xbody .
Exposure of human red blood cells to PEG-rnod i f i ed a n t i b o d y * ^
^rinses a s u b s t a n t i a l and s p e c i f i c i n c r e a s e in cel l p a r t i t i o n
i n t o the PEG-rich phase in a number of P E G - d e x t r a n a q u e o u s two
p!-.<-.r>e -systems. Pe r t inen t phase-system pa rame te r s were exe. .li ,iod .
Pol 1 owing a s ingle incuba t ion w i t h PEG-de r i va t i ^ed a n t i b o d y / a
»\
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m i x t u r e of sheep and h u m a n red blood cells was c o m p l e t e l y
separated in 100 m i n u t e s by a 3 0 - t r a n s f e r c o u n t e r c u r r e n t
extract ion using a two-phase system which normally offers little
resolution.
INTRODUCTION
There is considerable need both in b i o m e d i c a l ^.r^esea rch and
in diagnost ic medicine for reliable techniques for s p e c i f i c a l l y
separating a discrete population of cells f r o m a m i x t u r e . The
ideal technique should provide a good y ie ld of cells o f v , h i g h
u r i ty whi le cell funct ion is m a i n t a i n e d . The p r e s e n t w o r k
ind ica tes that immuno-a f f in i ty phase part i t ion has the potent ia l
for becoming such a technique. \ •
^
Aqueous solutions of low c o n c e n t r a t i o n s of the p o l y m e r s
dext ran and poly{ethylene glycol) ( P E G ) f o r m two-phase sys tems
consisting of a less d e n s e / P E G - r i c h phase f l o a t i n g on a
dex t ran- r ich phase. When b u f f e r e d and m a d e i s o t o n i c by the
addition of salts or other low molecular w e i g h t so lutes / these
aqueous polymer two-phase systems can be used for analytical and
preparat ive separation of a wide range of biological subs tances
%
i n c l u d i n g cells/ o rgane l l e s / nuc l e i c a c id s / and p ro te ins .
Separation results f rom d i f f e r e n t i a l par t i t ion ing of subs tances
ween the two phases or/ in the case of par t ic les/ between the
liquid-l iquid interface and e i ther of the phases. R e s o l u t i o n
c.^n be e n h a n c e d by the r e p e a t e d p a r t i t i o n i n g p r o v i d e d by
- 3 -
c o u n t e r c u r r e n t d i s t r i b u t i o n a n d c o u n t e r c u r r e n t
chroma tography. ~6
Factors which influence the partition of macromolecules and
particles i n c l u d e s i z e / s u r f a c e c h a r g e / a n d s u r f a c e
hydrophobicity. System characteristics such as in t e r fac ia l
tension and salt composition also in f luence part i t ion and can be
altered by changing the type and concent ra t ion of polymers and
salts.1"3 tf >/
Another method for altering parti t ion is through the use of
a f f i n i t y l igands. 2 A ligand t h a t s e l e c t i v e l y b i n d s to a
particle or macromolecule of interest is cova len t ly coupled to
of the polymers (typically PEG) . When mixed in a two-phase
sys tem/ and allowed to settle/ the PEG-bound l igand pa r t i t i ons
predominately into the phase rich in that po lymer / p u l l i n g the
* •
7 — 1 9 ^target material w i t h i t . These l igands may be spec i f i c /
such a s enzyme i n h i b i t o r s fo r e n z y m e p u r i f i c a t i o n / o r
n o n s p e c i f i c / l i k e d y e s f o r e n z y m e o r n u c l e i c a c i d
Q Q \")pur i f i ca t ion ' or fa t ty acid esters for cell pur i f ica t ion .
The present a r t i c l e descr ibes how we have r e f i n e d the
technique of phase partitioning to include speci f ic b ind ing of
cell surface ant igens by a n t i b o d y l i g a n d s a t t a c h e d to PEG.
*
Several steps are required to demonstrate the efficacy of
•a*
i m m u n o - a f f i n i t y cell part i t ion: (1) PEG must be a t tached to the
; (2) PEG-derivatized antibody ( P E G - A b ) m u s t p a r t i t i o n
into the PEG-rich phase and i t m u s t r e m a i n a c t i v e ; (3 ) t he
PEG-7ib rriust pull the cells of interest i n to the top phase ; and
- 4 -
(4) this cell partitioning must be selective for the targeted
cells.
We have chosen to examine the p a r t i t i o n i n g of h u m a n and
sheep red blood cells (RBC's) as a simple model system. RBC's ""
have been extensively studied in phase part i t ioning/ and have
the a d d i t i o n a l a d v a n t a g e o f b e i n g e a s i l y q u a n t i f i e d ; i n
addi t ion/ native antibodies are c o m m e r c i a l l y a v a i l a b l e for
immune-a f f in i ty parti t ioning of these R B C ' s . Alsc^/( / one aspect
of antibody ac t iv i ty can eas i ly be m e a s u r e d by m i c r o t i t e r
hemagglut inat ion assay; but it should be noted that PEG-modified
antibody may be rendered e f f e c t i v e l y m o n o v a l e n t / and thus may
Ftill be active and capable of b i n d i n g R B C ' s w h e n i t can no
longer agglutinate RBC's. We chose a polymer phase system in
which both human and sheep R B C ' s pa r t i t ioned in favor of the
\ •
interface and t h e n used P E G - b o u n d a n t i b o d i e s to the cell
membrane of the human RBC to specifically increase the parti t ion
of human RBC's into the top/ PEG-rich phase. The e f fec t s of
\\
phase-system parameters and the i n f l u e n c e of PEG m o l e c u l a r
weight and degree of derivatization were also invest igated. In
add i t ion / we have examined the usefulness of PEG-ant ibodies in
countercurrent distribution of cells.
•
M A T E R I A L S AND METHODS
Unless specified otherwise all reagents were ACS g r a d e / or
bet ter / qual i ty from commercial sources. D i s t i l l e d / f i l t e r e d /
12 Tnecjohm/cm water was used throughout .
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Antibody preparations
Rabbit IgG directed against stroma from human RBC's (nat ive
a n t i b o d y ) w a s ob ta ined f r o m Cooper B i o m e d i c a l / M a l v e r n /
Pennsylvania (lot 22196). Fab fragments derived from this same
lot were prepared by controlled papa in d i g e s t i o n by Jackson
Immunoresea r ch / A v o n d a l e / P e n n s y l v a n i a . An e n r i c h e d IgG
fract ion from sheep/ also directed a g a i n s t h u m a n R B C ' s / was
kindly provided by Dr. D. E. Brooks / U n i v e r s i t y of B r i t i s h
Columbia/ Vancouver. This f ract ion/ which had been der ived f r o m
whole serum by ammonium sulfate precipitation/ was then f u r t h e r
pur i f ied by ion exchange chroma tography using a DEAE-s i l ica gel
^ ^ l u m n . Both I g G samples a g g l u t i n a t e d h u m a n R B C ' s a t
concentrat ions less than 0.2 pg/ml but did not agglutinate sheep
RBC's .
%
Modif ica t ion of antibodies with PEG
In a typical preparation/ 12 mg of pro te in in 0.5 ml 0.05M
Na B.O7 / pH 9.2, was added to 1.5 ml 0.1M borate bu f f e r . One ml
of cyanur i c - c h l o r i d e a c t i v a t e d 1 4 ' 1 5 PEG 5000 or PEG 1900
monoinethyl ether in the borate bu f f e r was then added at 4CC/ and
the mix tu re was s t i r r ed for one h o u r . U n a t t a c h e d PEG was
removed by dia f il tra t ion (50 ml A m i c o n ce l l / PM-30 m e m b r a n e /
•
30/000 molecular weight cu t -o f f ) with 10 volumes of 0.05M borate
b u f f e r and 0.025M sodium azide to a f i n a l v o l u m e of two ml.
27 ing of act ivated PEG 5000/ a p p r o x i m a t e l y e q u i m o l a r
re la t ive to IgG lysine amino groups (90 per molecule) resulted
in about 50% modi f i ca t ion of the lysine amino groups; only 70 of
- 6 -
the 90 lysine groups were sensitive to our method of analysis
(below). About half this amount of activated PEG (14 mg ) gave
30% modification.
Analysis was performed by the Biuret and Habeeb methods as -'
described previously. ' For the la t te r m e t h o d (based on
reaction of trin i t robe n ze ne sul f on i c ac id w i t h f r e e ly s ine
groups)/ we found it necessary to remove u n a t t a c h e d PEG and to
keep protein concentrations at approximately 0.6 mg/ml in order
to obtain accurate and reproducible results. The 0.1M borate
buf fe r was used rather than 4% NaHCO_ called for in the original
O
procedure.
3C preparation
Blood samples were obtained by v e n i p j n c t u r e f rom hea l thy
individuals and treated with l O m M E D T A as an a n t i c o a g u l a n t .
\ •
Samples were used fresh following brief storage ""at 4°C. Shortly
before use/ one ml aliquots were washed four times by suspension
in twenty volumes of i so tonic b u f f e r ( I s o t o n I I , C o u l t e r
\\
Electronics/ Hialeah/ Florida) and centrif uga tion for 10 min at
1000 x G/ followed by removal of the supe rna t an t and the b u f f y
coat.
RBC quant i f ica t ion
%
Quant i f ica t ion of mixtures of sheep and h u m a n R B C ' s was
•afc
based on size d i f ferences as d i sc losed by an i m p e d a n c e cel l
er (Coulter Electronics/ Hialeah/ Florida) equipped w i t h a
100 channel size analyzer interfaced with an Apple 11+ computer.
In some exper iments agg lu t ina t ion hindered use of this n e t h o d /
- 7 -
and vis ible spectroscopy was used to m e a s u r e h e m o g l o b i n
concentrations and thus cell n u m b e r s . For th i s p r o c e d u r e /
partit ioning samples were cen t r i fuged at 1000 x G for 10 m i n /
the supernatant removed/ and 0.4 ml cyanomethemoglobin reagent
(Hycel / Houston/ Texas) was added to lyse the cells. A f t e r
cent r i fugat ion to remove cell s t roma (8800 x G for 10 m i n ) /
absorbance measurements were taken at 540 nm and compared to the
absorbance of a sample/ treated identically/ containing a known
w I/
number of cells.
Direct hemagglutination assay
The method for passive hemagglutination described by Amman
>'
Pclger*' was modif ied to d i rec t ly assay the a g g l u t i n a t i n g
abi l i ty of both PEG-Ab and native antibody fract ions. Human and
sheep RBC's (between one and 7 days o l d ) were c o l l e c t e d and
\ *
v.'-ished as described above. Packed/ washed cells (0 .05 ml) were
resuspended in 3.0 ml of solut ion-I (100 ml 0 .01H p h o s p h a t e
buf fe red sal ine/ pH 1.2, 1.6 ml 30% bovine serum a l b u m i n / and
100 mg dextrose) . This suspension could be kept for up to f ive
days a t 4 ° C . B e f o r e t e s t i n g / a f u r t h e r 1 :7 d i l u t i o n in
solution-i was made.
I n V - b o t t o m m i c r o t i t e r p l a t e s ( C o o k e E n g i n n e r i n g /
Alexandr ia / V i r g i n i a ) serial two-fo ld d i lu t ions (0 .05 ml) of
each sample to be tested were made u s ing solut ion II (100 ml-*
0.01M phosphate buffered sa l ine / pH 7 .2 / 0.05 ml Tweon 80/ 1.0
g polyvinylpyrrol idone / and 1.5 ml 30% BSA) . H u n a n .amT sheep
cr
RBC's (0.05 ml) were added to each well.
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Microtiter plates were placed on an automatic rotator shelf
for mix ing (10 m i n ) and then i n c u b a t e d on a f l a t s u r f a c e
overnight at 25°C. Prior to screening, plates were elevated at
a 60° angle for 15 min. Positive agglut inat ion resulted in no
"run-down" pattern of RBC's. Resul ts were expressed as the
m i n i m u m concentration of a n t i b o d y w h i c h caused a p p r e c i a b l e
agglu t ina t ion .
Preparation of two-phase systems
P o l y m e r p h a s e s y s t e m s w e r e p r e p a r e d aa"'d e s c r i b e d
o O C
previously ' by mixing appropriate weigh ts of the fo l lowing
aqueous stock s o l u t i o n s ( a l l % w / w ) : 20% d e x t r a n T500
(Pharmac ia / Piscataway/ New Jersey/ lot IE32126 or lot HD26066) ;
PEG 8000 (Union Carbide/ lot B529-9104 or lot B-739) ; 20%
dex t r an T 4 0 (Pharmacia / l o t F L 1 8 9 7 4 ) ; 0 . 6 M N a C l ; a n d 0 . 2 2 M
, 0.07M NaH2PO4/ pH 7.2 buf fe r . S o d i u m * az ide was added
to a f ina l system concen t ra t ion of 0 .02% to re tard bacterial
c o n t a m i n a t i o n . C o n c e n t r a t i o n s o f d e x t r a n so lu t ions w e r e
determined by po la r imet ry . All o ther concen t ra t ions were
determined graviinetrically . A f t e r p r e p a r a t i o n / phase systems
were sterilized by f i l t ra t ion th rough a 0.2 micron f i l t e r and
allowed to settle at room t empera tu re o v e r n i g h t . The phases
were then separated and s to red at 4° C but r e t u r n e d to room
temperature before use.
Seven well characterized two-phase polymer systems were used
this work:2 '5 '1 8 (a) ( 5 / 4 ) I / 5% d e x t r a n T500/ 4% PEG 3000/
109 nil Na2HP04 , 35 mM NaH2PO4 / pH 7.2 ( b u f f e r I); (b) ( 5 / 4 ) 1 1 ,
- 9 -
5% dextran T500, 4% PEG 8000, SOraM NaCl, 73 mM Na 2 HPO 4 / 23mM
P04/ pH 7.2 (buffer II); (c) (5/3. 5)V, 5% dextran T500, 3.5%
PEG 8000, 150 mM Nad/ 7.3mM N a 2 H P O 4 / 2 . 3 m M N a H 2 P 0 4 , pB 7.2
(buffer V); (d) (4.6,3.9)V, 4.6% dex t ran T500, 3.9% PEG 8000/
„.-*
buffer V; ( e ) (5 ,4 )Y, 5% dextran T500, 4% PEG 8000, buffer V; (f)
( 7 , 4 ) V , 7% dextran T500, 4% PEG 8000, b u f f e r V; (g) ( 7 , 5 ) V , 7%
dextran T40, 5% PEG 8000, buf fe r V.
These s y s t e m s w e r e c h o s e n to r e p r e s e n t a r a n g e of
interfacial tensions, electrostatic bulk phase potentials , and
1—5 18dextran molecular weight.
Single tube partition
The ability of various concentrations of PEG-Ab to increase
the partition coefficient K (the ratio of cells in the top phase
to the r e m a i n d e r of ce l l s ) of h u m a n R B C ' s was s t u d i e d in
single-tube experiments. In 12 x 75 mm tube's', 0.5 ml u p p e r
phase containing 2 x 10 human RBC's was incubated wi th 0.2 ml
PEG-Ab solution for 15 rain at 37°C. The cells were pelleted by
centrif ugation at 1000 x G for 10 min and the s u p e r n a t a n t was \\
removed. Af ter being washed once in f r e sh upper phase, cells
were resuspended in 1.0 ml upper and 1.0 ml lower phase. The
suspension was mixed by invers ion t w e n t y t imes and a l lowed to
settle 15 min for e q u i l i b r a t i o n . M i x i n g was r e p e a t e d , the
system allowed to settle for 15 min and 0.7 ml of top phase was*
.then promptly removed. A port ion of this sample (0 .2 ml) was
usod fo r i m p e d a n c e c o u n t i n g and the r e m a i n i n g 0 .5 ml was
cen t r i fuged and quan t i f i ed by spec tropho tome t r ie ana lys i s , as
- 10 -
described above.
Inhibition studies
Prior to single tube partitioning/ 0.5 ml human RBC's at a
concentration of 4 x 10 /ml in upper phase was f i rs t incubated
„-•*
at 37°C for 15 rain with O.2 ml of unmod i f i ed Fab. Cells were
then washed once in fresh upper phase and resuspended in 0.5 ml
upper phase for incubation with PEG-Ab.
Antibody partition
Both PEG-Ab and native antibody preparat ions C-0/. 2 ml) at a
concentration of 2 rag/ml were added to two ml of a ( 5 / 4 . 2 5 ) V
system to produce a ( 4 - 9 / 3 . 6 ) V s y s t e m . Each tube was m i x e d
twenty times by inversion and allowed to equil ibrate for 15.- min.
|fter remixing/ the systems were c e n t r i f u g e d at 1000 x G for 5
min . An aliquot of the resulting upper phase was mixed w i t h an
equal volume of bu f fe r and its absorbance measured at 280 nm.t •
«^
This value was compared to that of the 100%-con t ro l t ube in
which 0.2 ml of the original sample was added to 0.9 ml of upper
phase and 1.1 ml bu f fe r .
\\
BSA partition
Comparison of the p a r t i t i o n of u n m o d i f i e d b o v i n e s e rum
albumin (BSA) and PEG-modified BSA was carr ied out in a ( 5 / 4 ) V
system as follows: Preparations (0.1 ml) at a concentration of 4
»
mg/ml were added to 2 ml of phase system. Tubes v/ere m i x e d by^
vortexing t w i c e a t 1 0 m i n u t e i n t e r v a l s / a n d w e r e t h e n
tr i fuged 5 minutes at 200 x G. Aliquots from each phase (0.7
ml) were diluted to 3 ml w i t h PBS and f l u o r e s c e n c e e x c i t e m e n t
- 11 -
and monitoring were done at 280 nm and 380 nm/ respectively/ in
a Turner spectrofluorometer with the appropriate phase acting as
a zero control.
Automated CCD experiments
Countercurrent distribution (CCD) experiments were performed
as previously described,1"3'5 using a 60-chamber Biosheff MK II
apparatus (Biochemistry Department/ University of Sheffield/
Sheffield/ England). The lower cavity volume for this machine
tr I/
is 850 pi. Since all runs described in this work cons is ted of
30 t ransfers / either duplicate or two d i f f e r e n t e x p e r i m e n t s
could be run s imultaneously, one on ei ther side of the rotor.
V
Antibody treatment of RBC's consisted of incubat ing cells or
mix tu r e s of cells with PEG-Ab (1.3 mg/ml ) at 37°C for 15 minu tes
in the same proportions as for the s i n g l e tube p a r t i t i o n i n g
experiments . Af te r incuba t ion / cel ls w e r e - washed once w i t h
f resh upper phase and resuspended to a load mix concent ra t ion of
•7
2-4 x 10 cells per ml of upper p h a s e . For p a r t i t i o n i n g of
cells/ 800 ul of l o w e r phase was a d d e d to e a c h of the 60
cavities. 900 pi of sample load mix was a d d e d to c a v i t i e s
0,1/30, and 31. 900 pi of upper phase a lone was added to the
r e m a i n i n g cavities. In every run, a m i x i n g t ime of 12 seconds
end a sett l ing time of 3 minutes was used. Phases were b roken
b y adding 1 . 0 m l o f b u f f e r t o e a c h c a v i t y . C e l l s w e r e *
q u a n t i f i e d as described above.
RESULTS AMD DISCUSSION
- 12 - ORIGINAL PAGE IS
OF POOR QUALITY
Antibody modification
Of the several methods available for protein-PEG coupling/ ^
we chose the method of Abuchowski and Davis in which the PEG
is first activated with cyanuric chloride and then coupled to
lysine groups on the protein/ eq. 1. '
riCl
Using this reaction we could v a r y the n u m b e r of l y s i n e s
fubs t i tu ted w i t h PEG (as shown by r educ t ion in the number of
primary lysine amino groups).
The effect of PEG substitution on protein par t i t ioning in a
polymer two phase system was f i r s t t es ted w i t h b o v i n e s e r u m
albumin ( B S A ) / Table 1. As can be seen f rom the sh i f t s in BSA
part i t ioning/ a t t ach ing PEG to a protein can have a d rama t i c
U
e f f e c t o n p r o t e i n p a r t i t i o n i n g . S i m i l a r l y / a n t i b o d y
par t i t i on ing can a l so be s h i f t e d to f a v o r the top p h a s e /
al though partit ioning shifts are not as d ramat i c as wi th BSA/
Table 1. Nonetheless/ modified ant ibody was f o u n d to s t rongly
favor the top phase/ i n d i c a t i n g t h a t the p roposed a f f i n i t y
parti t ioning was feasible and that the par t i t ion behavior of
l i g h MW molecules could be altered by PEG coupling.
Ear l ier works/ ' ' especially those o f Abuchowsk i and
Davis have amply d e m o n s t r a t e d tha t P E G - s u b s t i t u t e d e n z y m e s
- 13 -
remain active although the loss of activity resulting from
substitution can be severe with some enzymes and with some
coupling methods. The present study is the first to our
2 2knowledge u t i l iz ing PEG-substituted antibody. As shown in
Table 2, PEG-Ab loses some of its ability to agglut inate human
RBC's . This effect shows an apparent dependence on PEG MW/ the
higher MW c a u s i n g m o r e d ea c t i va t i on . The e f f e c t of %
substitution on antibody activity is not a s imple r e l a t ionsh ip
W I/
since the PEG 5000 is more active with a h ighe r % subs t i t u t i on
while the PEG 1900 i s less a c t i v e / T a b l e 2 . H o w e v e r /
measurements of a g g l u t i n a t i o n and %-s ub s t i t u t i o n are
u f f i c i e n t l y a p p r o x i m a t e t o m a k e th is l a t t e r c o n c l u s i o n
uncertain. We are presently us ing more precise t echn iques to
examine the ef fects of PEG substitution on enzyme activity. For
the present study, however/ these e f f e c t s are^ not of cr i t ical
importance/ since all that is needed is PEG-substituted antibody
which is active and partitions to the top phase. In a control
experiment PEG-Ab (ant ibody f rom sheep) was shown to have no
agglut inat ing activity toward sheep RBC's .
Single tube partition
Next the ability of the PEG-Ab to alter the pa r t i t ion ing of
human RBC's was examined. These resul ts are shown in Table 3
•
and Figures 1 and 2. As we had hoped/ the PEG-modif ied antibody
is quite e f fec t ive at pul l ing h u m a n R B C ' s in to the top phase;
increase in pa r t i t i on varies d i r ec t l y w i t h the a m o u n t of
PEG-Ab added. Note also that the par t i t ioning sh i f t is observed
- 14 -
with both sheep- and rabb i t -de r ived a n t i b o d y . U n m o d i f i e d
an t ibody did not al ter RBC p a r t i t i o n / e i ther because of
extensive agglutination and s e d i m e n t a t i o n or because PEG is
necessary to pull the cells into the PEG-rich phase.
Antibody modified with PEG 5000 gives more dramatic effects/
especially evident at the higher c o n c e n t r a t i o n s of m o d i f i e d
antibody; for example/ at 171 _ug/ml the PEG-5000 conjugate gave
an average % partition of 85 while the PEG-1900 con juga t e gave
an a v e r a g e % p a r t i t i o n of 59. I n t e r e s t i n g l y / the least
ggglut inat ing PEG-Ab gave -the highest % parti t ion; with the more
Active antibody/ agglutination and sedimentation of cell clumps,
was a problem. Thus it appears that the reduct ion in an t ibody
a g g l u t i n a t i n g a b i l i t y w h i c h r e su l t s upon PEG c o u p l i n g i s
advantageous from the standpoint of a f f i n i t y par t i t ioning.
Finally/ i t r e m a i n s to d e m o n s t r a t e t h a t the P E G - A b is
selective in pul l ing only specific cells into the top phase.
Single-tube control experiments clearly showed that partitioning \\
of sheep RBC's was unaf fec ted by PEG-niodi f ied an t ibody . Thus
all the components of i m m u n e - a f f i n i t y phase p a r t i t i o n i n g of
cells are in hand: PEG-modified antibodies will dramatically and
%selectively shif t the pa r t i t ion ing of the targeted cells in to
the top PEG-rich phase. "*
^^ In a related s t u d y / Sharp et a^- have shown tha t h u m a n
RBC's bind a p p r o x i m a t e l y 1 5 / 0 0 0 P E G - A b m o l e c u l e s o f
rabbit-derived a n t i - h u m a n antibody. This s t udy ind ica t e s tha t
the present t e chn ique may be appl icable to cells h a v i n g this
PAGE is
POOR
approximate receptor density.
As an additional control exper iment / we also examined the
ability of monovalent Fab fragments prepared f rom the same lot
^
of rabbit IgG anti-human RBC (unmodified by PEG a t t achment ) to
inhibit the shift in human RBC partitioning that results in the
presence of PEG-modified ant ibody. For th i s e x p e r i m e n t the
following concentrations were used: Fab/ 686 ug/ml ; 47% modified
PEG-5000 IgG/ 600 pg/ml ; and 2 x 10 human RBC's "i'n 2 ml of a
(4.6/3.9) phase system. In the absence of Fab 89% of the RBC's
partit ioned to the top phase. Incubation of the cells w i t h Fab
or to their i n c u b a t i o n wi th pEG-Ab gave a r e d u c t i o n in
par t i t ion ing t o 6 9 % ( e x p e c t e d f r o m 1 5 0 u g o f P E G - A b ) .
U n f o r t u n a t e l y / th is e x p e r i m e n t w a s c o n f u s e d s o m e w h a t b y
unexpected cell aggregation by the Fab ( w h i c h , s u r p r i s i n g l y /
occurred in phase system but not in b u f f e r ) . None the less / Fab
did compete with the PEG-modified IgG in binding wi th the R B C ' s
and thus gave a reduction in the a f f i n i t y part i t ioning effect . \\
System variation
After these initial experiments/ several other phase systems
were examined to determine the effects of var ious phase sys tem
parameters on a f f i n i t y p a r t i t i o n i n g / Table 4. In b r i e f / we
observed that PEG-Ab addition produced the most d ramat ic shifts*"
Ln cell par t i t ion in systems hav ing a low i n t e r f a c i a l t ens ion
and a low electrostatic b u l k phase p o t e n t i a l . As w o u l d be
expected, increasing the in ter fac ia l tension pulled the cells to
the in t e r face / making i t more d i f f i c u l t to pul l the cells in to
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either phase (e .g . / compare the ( 5 / 3 . 5 ) V / ( 5 / 4 ) V / and ( 7 / 4 ) V
systems).
The effects of electrostatic bulk phase potent ia l are
diff icul t to determine since increas ing po ten t i a l (by salt
variation) is accompanied by an increase in interfacial tension
(e .g . / compare the I/ II/ and V versions of the 5/4 sys tem) .
Generally/ however/ it appears that increasing the potential is
counterproductive for a f f in i ty par t i t ioning since *i't increases
the partition coe f f i c i en t K ( r a t i o of cells in top to the
remainder of cells) in the absence of a f f i n i t y l igand. Also /
he high interfacial tension for high potent ia l systems ( e . g . /
( 5 / 4 ) 1 ) makes it d i f f icul t for the a f f i n i t y ligand to pull cells
a w a y f r o m the i n t e r f a c e ; no te the dec rease in p a r t i t i o n
coefficient in the presence of ligand upon mov*ing f rom V to II
to I versions of the 5/4 system. The net result is that the
largest shifts in parti t ioning f r o m l igand addi t ion are found
wi th the low tension systems such as the ( 5 / 3 . 5 ) V system. \\
The f inal entry in Table 4 is for a ( 7 / 5 ) V system made f r o m
dextran of 40/000 molecular weight. The lower dextran molecular
T 2
weigh t / as expected/ gives a lower pa r t i t i on c o e f f i c i e n t /
wi th a significant percentage of the cells moving to the lower /
dextran-rich phase. This system appears to be of little use for*
inity part i t ioning since the ligand acts to move cells f r o m
the bottom phase to the i n t e r f a c e / w h i c h a l r e a d y c o n t a i n s a
large number of the cells. However/ it is n o t e w o r t h y t h a t the
PEG-Ab binding is p o w e r f u l e n o u g h to pul l the cells f rom the
t- 17 -
bottom phase.
Finally, it should be noted that the ( 4 . 6 / 3 . 9 ) V en t ry
(without ligand) for Table 4 is quite d i f f e ren t from the same
entry for Table 3. These two results d i f f e r because d i f f e r en t
lots of PEG-8000 were used. It is not uncommon in par t i t ioning
to observe this sort of u n e x p l a i n e d d e p e n d e n c e on p o l y m e r
lots.18
Countercurrent distribution
The shifts in partitioning produced by adding PEG-Ab are not
large enough to produce total separation in one step. This is a
v
^|miliar situation in phase p a r t i t i o n i n g wi th aqueous polymer
two-phase systems/ and the u sua l a p p r o a c h is to u t i l i z e an
automated device which provides repeated pa r t i t i on ing . In
the present case we h a v e p e r f o r m e d t h i r ty,-t ra n s f e r CCD
experiments with a Biosheff MK2 apparatus. In a CCD device the
cells are mixed with the two-phase system in one cav i ty / then
the top phase is shifted to the ad j acen t bottom phase and the
bottom phase is shifted to the a d j a c e n t top p h a s e / F ig . 3.
These a f f i n i t y CCD experiments could be per fo rmed in two ways.
Either PEG-Ab could be added to every c a v i t y / in which case a
large quanti ty of PEG-Ab would be required/ or the cells could
be incubated once with the PEG-Ab prior to CCD; in this la t ter*
little PEG-ligand would be required.
In Figure 4 we have p r e s e n t e d the r e s u l t s of t h r e e CCD
experiments . in the f i r s t / Figure 4a / u n t r e a t e d h u m a n R B C ' s
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circles) and human RBC's previously incubated with PEG-Ab for
15 minutes at 37° C ( t r i ang les ) were sub jec ted to separa te
/
thirty-transfer CCD runs. As would be expected on the basis of
the higher partition coefficient for human RBC's in the presence
of PEG-Ab (from single tube e x p e r i m e n t s ) / the h u m a n R B C ' s
^
incubated with PEG-Ab gave a peak well separated from that of
the u n t r e a t e d h u m a n R B C ' s . F o r t u n a t e l y / t he i n c u b a t i o n
technique provided suff ic ient exposure of the RBC's to antibody/
thus dramatically reducing the a m o u n t of P E G - A b r equ i r ed to
perform CCD experiments. *"
The e x p e r i m e n t o f F i g u r e 4 a was p e r f o r m e d w i t h
rabbit-derived PEG-Ab with 30% of the lysines subst i tuted by
•3
. This p a r t i c u l a r PEG-Ab sample gave e x t e n s i v e cell
agglutination. To avoid cell sedimentation in this case we used
a large excess of PEG-Ab in our incubation procedure to lessen
the likelihood of a particular antibody encounter ing more than
one cell. Interestingly/ not all PEG-Ab preparations gave this
same behavior. For example in Figure 4c we show a CCD curve for
untreated and treated human RBC's in which i ncuba t ion was done V
with a relatively small amoun t of PEG-Ab in which the IgG was
rabbit-derived and had 47% of its lysines substituted wi th PEG.
In this case an antibody excess was not requi red because cell
"sedimentation was m i n i m a l . The poor separa t ion of Figure 4c
results apparently because insuf f ic ien t PEG-Ab is bound to the**"
human cells. In Figure 4b we show CCD curves for the weakly
agglut inat ing a n t i b o d y o f F i g u r e 4 c b u t a t t h e s a m e
- 19 -
Concentration as in Figure 4a; near ly id.entical results are
obtained.
These results emphasize that appreciable variation in PEG-Ab
preparations was found. On the negative side/ we must say that
the origin of this variation is unclear/ while on the positive
side/ we can note that all the v a r i a n t s were e f f e c t i v e in
immuno-affinity cell partitioning.
Prior to attempts to separate m i x t u r e s of h u m a n and sheep
RBC's/ control e x p e r i m e n t s were d o n e / F igu re 5. In these
experiments/ sheep and human RBC's which were not incubated with
PEG-Ab revealed identical CCD behavior/ with both RBC's peaking
in early fractions.
V
In our f inal experiment/ shown in Figure 6/ sheep and human
RBC's were mixed/ incubated wi th PEG-Ab/ then subjected to a
thirty-transfer CCD run. Again/ the human and sheep RBC's were
cleanly separated/ with the human RBC's moving 'far down the CCD
train.
SUMMARY
In summary/ we have demonstrated that immuno-aff in i ty phase
partitioning with PEG-modified antibodies as a f f i n i t y ligands is
an ef fec t ive technique for cell pu r i f i c a t i on in an erythrocyte
, fnodel system. This advance might reasonably be expected to be
applicable to cell s e p a r a t i o n s of s i g n i f i c a n t b i o m e d i c a l
^interest. Work is in progress in our laborator ies to explore
this prospect.
- 20 -
ACKNOWLEDGEMENT. JMH and LJK thank NASA for financial support
of this work through contracts NAS8 -35593, -35334,.and -35362.
JMVA received a fellowship from the Universities Space Research
Association. The authors thank D. E. Brooks and K. A. Sharp for
providing materials and assistance throughout this project.
REFERENCES
1. P. A. Albertsson/ "Partition of Cell Particles and
V \/
Macromolecules/" 2nd. ed . , Wiley In terseience/ New York/
1971.
2. H. Walter/ D. E. Brooks, and D. Fisher, Z£.£^ i^ .i°.Ein.9__in.
vr
Aqueous Two-Phase Sys t e m s , A c a d e m i c Press , O r l a n d o , in
press.
3. H. Walter, in "Methods in Cell Separation," N. Catsimpoolas,
Ed. , Vol. 1, Plenum, New York, p. 307-354.'-
4. D. Fisher, Biochem. J., 196, 1 (1981).
5 . (a) J . M. H a r r i s , M. G. C a s e , R. S. S n y d e r , and A. A.
Chenault , J. Liq. C h r o m . , •]_, 419 ( 1 9 8 4 ) ; (b) J. M. Van
Alstine, L. J. Karr, R. S. Snyder, and J. M. Harr is , ibid. ,
in press.
6. S. D. F l anagan , G. Johansson , B. Yost , Y. Ito, and I. A.
Suther land, ibid. , T_' 385 (1984).
7. P. Hubert , E. Dellacherie, J. N e e l , and E. B a l i e u , £_§.§.s_
Lett . , 65_, 169 (1976) .
8. (a) K. H. Kroner , A. Cordes, A S c h e l p e r , M. H o r r , A. F.
Buck-nann , and H. R . K u l a , in " A f f i n i t y C h r o m a t o g r a p h y a- id
2, ORIGINAL PAGE IS
OF POOR QUALITY
Related Techniques," T.C.J. Gribnau, J. Visser / and R.J.F.
Nivardf Eds., Elsevier, Amste rdam, 1982, pp. 491-501; (b)
G. Kopperschlager, G. Lorenz, and E. Usbeck, J. Chrom., 259,
97 (1983); (c) G. Johansson, M. Joelsson, B. Olde, and V.
P. Shanbhag, J. Chrom., 331, 11 (1985).
9. W. Muller, I. Hattesoho, H. Schuetz, and G. Meye r , Nucleic
Acids Res., 9, 95 (1981).
10. S. D. Flanagan, Receptor Biochem. Hethodol. , 2, 15 (1984).
*• \f
11. T.G.I. Ling, .M. Ramstorp, and B. Mattiasson, Anal. Biochem.,
122, 26 (1982).
12. J. M. Harris, M. G. Case, B. A. Hovanes, J. M. Van Als t ine ,
v'
and D. E. Brooks, Ind. Eng . C h e m . / Prod. Res. Dev. , 23, 86
(1984).
13. S. K. Kundu, Meth. Enzym. / 72, 174 (1981).
14. A. Abuchowski, T. van Es, N. C. Palczuk, and F. F. Davis/ J.
Biol. Chem., 252, 3578 (1977).
15. S. G. Shafer arid J. M. Harris, J. Polym. Sci./ Polym. Chem.
Ed., 23, 0000 (1985).
16. G. M. Edelman, B. A. Cunn ingham, W. E. Cell, P. D. Gottlieb,
U. Rutishaufer, and M. J. Waxdal, Proc . Nat. Acad. Sci., 63,
78 (1969).
17. A. J. Ammann and R. J. Pe 1 g e r , J\p p l^_M_i£££bi. . , I4t 323
(1966).
. S. Banberger, D. E. Brooks/ K. A. Sharp/ J. M. Van Als t ine ,
and T. J. VIebber, in P a r t i t ion ing i n Aqu e ou s Two - Piia se
Systems/ H . W a l t e r / D . E . B r o o k s , a n d D . F i s h e r / E d s . /
imrff^ «n ii 4i
- 22 -
Academic Press, Orlando/ in press/ Chapter 3.
19. J. M. Harris/ J. Hacromol. Sci.-Rev. Macromol. Chem. Phys. /
C25/ 325 (1985).
20. S. G. Shafer and J. M. Harris, J. Polym. Sci., Polym. Chem^
Ed. / submitted.
21. C. O. Beauchamp, S. L. Gonias, D. P. Menapace/ S. V. P i z z o /
Anal . Biochem., 131/ 25 (1982).
22. K. A. Sharp, M. Yalpani / S. J. Howard , and D. E. Brooks/
f i/
Anal. Biochem., submitted.
Table 1. Effects of PEG substitution on BSA and native antibody
partitioning in dextran/PEG two-phase systems.
protein modified
BSA8
BSA
BSA
BSA
BSA
native-Ab
native-Ab-
% of lysines
modified
0
10
39
47
76
0
47
% partition
31 +
89 t
96 t
96 t
98
50 t
87 t
3
3
1
1
3
3
— Bovine serum albumin in a (5,4)V system, dextran T500, PEG
8000; see Materials and Methods. — Sheep IgG anti-human RBC's
 v
in a (4.6,3.9)7 system; dextran T500, PEG 8000; see Materials
c •»
and Methods. — Percentage of total protein partitioning into the
upper phase; BSA (x -SD, n = 2); native-Ab (x -SD, n = 4).
Table 2. Effects of PEG substitution on ability of antibody to
agglutinate RBC's.
PEG M *
V
Control
A —
B -
C -
D -
E -
5000
5000
5000
1900
1900
% of ly sines
modified
0
27
40
51
45
70
minimal henagglu-
tination concentration
(pg/ml)
<0.2
23-8
19-8
5*2
1*0
'"3 t 1
— Molecular weight of PEG used for substitution of sheep IgG anti-
huraan RBC's. Letter designation refers to Figure 1;-•"—Lowest
 >r
antibody concentration exhibiting appreciable heinagglutination in
I >
microtiter assay (x - SD, n = 3).
•
Table 3. Partitioning of human RBC's as a
.OIL,.'. .....* -^_. ...,^_
function of PEG-Ab concentration
and degree of antibody modification.
. - - b '"Z partition
Modification* [PEG-Ab]
(Z-MW-origin) (ug/ml)
27Z-5000-SHE - A
40Z-5000-SHE - B
50Z-5000-SHE - C
45Z-1900-SHE - D
70Z-1900-SHE - E
47Z-5000-RABC
5.35
47
33
36
41
40
3.0
10.7
46
39
38
34
45
3.0
21.4
49
48
38
39
46
4.0
42.8
53
56
45
44
47'
12
85.7
79
77
54
55
" 54
35
•i
171 i
92 ;
*J
84
80
57
61
80
•%
— Given as % lysines modified by PEG; MW of PEG used; and origin (sheep
b *
or rabbit) of antibody; A-E designation refers to Figure 1. — Duplicate
determinations with average standard deviation of 2.4Z. Partitioning was
done in separate batches of (4.6,3.9)V-phase system (dextran T500, PEG
8000; see Materials and Methods). In absence of PEG-Ab 2% partition of
human RBC's was observed in the rabbit experiments and 35Z in the sheep
experiments (see" Discussion). —Additional values of [PEG-Ab]/% partition
322/93; 643/90; 1286/84; and 2200/83.
Table 4. Effect of phase system composition on ability of PEG-Ab to
induce alteration of RBC partition.
Two-phase
a
system
(5,4)1
(5,4)11
(5,3.5)V
(4.6,3.9)7
(5,4)V
(7,4)V
(7,5)Va
interfacial
tension (uN/m)
11.0
8
0.7
3
4.9
17.2
5.0
electrostatic
bulk phase .
potential (mV)
2.2
1.0
0.2
0.2
0.3
0.2
0.2
cell
location
upper
upper
upper
upper
w \>
upper
upper
upper — '
interface
^
lower
d% partition
no PEG-Ab
14 ±1
6±1
2±1
2±1
o t i
o i l
oil
45 t 3
55 ±3
PEG-Ab
58 - 4
64-1
77 ±1
69 ±3
30-1
4±2
1 + 1
97 t 3
3il
— All systems compounded with PEG 8000 and dextran T500 of the sar:e lots
except (7 f5)V which was prepared with dextran T40; see Materials and "ethods.
b c
— Taken from reference 18. — Referring to the upper or lower phase or to
the interface between them. — Mean - SD of two independent determinations
using 643 ug/ml .of PEG-Ab (from rabbit).
Figure Legends
Figure 1. E f f e c t s of PEG m o l e c u l a r ^ w e i g h t / ex tent of.
mod i f i ca t ion / and incubation concent ra t ion of PEG-Ab
(derived from sheep) on the upper-phase a f f i n i t y (log K)
• -— - *"
human RBC. K is defined as the ratio of the number of cells^:
in the top phase to the r e m a i n d e r . A: PEG 5000/ 27%
, - """» 7Wf-v-'V'l«* -"•••
 t i
* ' " ;^trl!f-f^ i!
modif ica t ion; B: PEG 5000/ 40% m o d i f i c a t i o n ; C: PEG 5000/, . j£&^P3$£f|
51% modif ica t ion; D: PEG 1900/ 45% m o d i f i c a t i o n ; E: PEG ' '
]
1900/ 70% modification.
Figure 2. Effect of incubat ion c o n c e n t r a t i o n of PEG-Ab
(der ived from rabbit) on the upper-phase a f f i n i t y (log K) of
*human RBC.
j
Figure 3. Thin-layer countercurrent d i s t r ibu t ion (CCD) in
aqueous polymer two phase systems. The phases are mixed /
allowed to s e p a r a t e / ' and m a t e r i a l d i s t r i b u t e d b e t w e e n
cavities is separated by transferring the upper cav i ty onto
a fresh lower cavity. This process can be repeated ( f r o m
ref . 5).
Figure 4. Superimposed t h i r t y - t r ans fe r CCD runs of h u m a n
RBC in a ( 4 . 6 / 3 . 9 ) V two phase system. A: RBC incubated with
1.3 mg/ml PEG-Ab (30% modi f i ca t ion) and washed pr ior to CCD
(A); control RBC incubated in b u f f e r on ly and washed prior
to CCD. B: Identical to A except a d i f f e r e n t preparation of
pEG-Ab used f o r i n c u b a t i o n ( 4 7 % m o d i f i c a t i o n ) . C :
Identical to B except that an incubat ion concen t ra t ion of
0.325 mg/ml was used.
Figure 5. Superimposed thirty-transfer CCD runs of human (O)
and sheep (Q) R B C ' s in a ( 4 . 6 / 3 . 9 ) V two-phase s y s t e m .
Results are averages of four runs for h u m a n and seven runs
m- l/
for sheep.
Figure 6. Thirty-transfer CCD of a m i x t u r e of 7x10 hunan
'^
(O) and sheep (D) RBC' s in a ( 4 . 6 / 3 . 9 ) V two-phase system
following incubation wi th 1.3 mg/ml ?EG-Ab-.(f rom rabbi t ) and
vashing with phase system to remove unabsorbed antibody.
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